(CMR) Infanrix Hexa – a vaccine for children has been recalled by the manufacturer, that's according to the ministry of health in Trinidad and Tobago.
According to the ministry, drug manufacturer GlaxoSmithKline (GSK) has initiated a voluntary recall of Batch A21CD706B of Infanrix Hexa.
The vaccine is used in children for protection against diphtheria, tetanus (lockjaw), pertussis (whooping cough), hepatitis B, poliomyelitis (polio) and Haemophilus influenzae type b diseases.
It is understood that the recalled vaccines were stored under inappropriate storage (temperature) conditions during importation, which can affect the stability of the vaccine components, thus reducing its effectiveness
The ministry noted that the recall was voluntary and had been done out of an abundance of caution.
” The vaccine is not used in the public health sector and hence the recall is confined to private medical facilities and at private doctors’ offices,” added the release.
A search of the GSK worldwide safety database did not identify any reported adverse events that appear to be linked to contamination.
Infanrix Hexa was recalled in 2012 after the detection of contamination in the environment where material used to make the recalled vaccine had been placed.